A study to compare efficacy of Abhyanga with Mahanarayana taila as an add on to the standard of care versus standard of care alone in chemotherapy induced peripheral neuropathy
- Conditions
- Health Condition 1: G620- Drug-induced polyneuropathy
- Registration Number
- CTRI/2023/11/059688
- Lead Sponsor
- Dr Namboodiri Aiswarya Raman
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Neuropathy attributed to chemotherapeutic agents with no prior history of attributable cause for chemotherapy induced peripheral neuropathy.
2)Eastern Cooperative Oncology Group (ECOG) Performance Status less than or equal to 3.
3)Self-reported neuropathy score greater than or equal to 3 on 0-10 scale and/or grade 2 or 3 neuropathy according to NCI-CTCAEv5 criteria.
4)Life expectancy more than 3 months.
5)Those who are willing to participate in this study and sign informed consent forms.
1)Peripheral neuropathy other than those induced by neurotoxic chemotherapeutic agents.
2)Abnormal cognition and speech - causing difficulty in comprehension, expression and signing informed consent
3)Age below 18 and above 60 years.
4)Pregnancy, lactating mothers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method